Embody vs Trimi Health
A promotional monthly rate against an annual plan billed up front.
Embody
Editorial
$79/mo
Embody shows $79 a month for compounded semaglutide and $129 for compounded tirzepatide, both struck through from higher anchors, and both reached by a promotion applied automatically at checkout. Its terms list $199 a month. The oral preparations are priced separately at $229 and $329.
Pick it for: Readers who want to start without a year committed
Trimi Health
Editorial
$99/mo
Trimi Health advertises $99 a month for compounded semaglutide and $125 for compounded tirzepatide, and bills both as an annual plan: $1,188 and $1,500, charged up front or split through a buy-now-pay-later provider. The rate is stated as flat across doses.
Pick it for: Readers who will pay a year up front to hold the rate
Our verdict
Embody's headline is promotional and time-limited. Trimi Health's $99 comes on an annual plan billed in advance. One expires, the other has to be paid for in full first.
What actually separates them
Embody and Trimi Health state different things about published price. Everything else they publish, they publish the same way.
Trimi Health costs $20 more than Embody — 25% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $948 at Embody against $1,188 at Trimi Health — a difference of $240.
| Embody | Trimi Health | |
|---|---|---|
| Published price | $79/mo | $99/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.